Form 4: Royalty Pharma CEO Pablo Legorreta Reports Share Transfers and Gifts

CEO Pablo Legorreta reports an exempt gift of Class B ordinary shares from his spouse and a transfer of Class B shares to PL RPH AIV, LLC, a company he solely owns.

Summary

• Pablo G. Legorreta, CEO and Chairman of the Board of Royalty Pharma plc, filed a Form 4 detailing changes in beneficial ownership.
• On May 12, 2025, Legorreta received an exempt gift of 867,180 Class B ordinary shares from his spouse.
• These shares were originally received by his spouse in an exempt pro rata distribution.
• Also on May 12, 2025, Legorreta transferred 9,700,000 Class B shares to PL RPH AIV, LLC, a company solely beneficially owned by him.
• These shares were originally received in exempt pro rata distributions and the gift transaction reported in this filing.
• Each Class B share is convertible into one Class A ordinary share.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing share transfers and gifts, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Related Party Transactions

• The exempt gift of Class B ordinary shares from the reporting person's spouse to the reporting person is a related party transaction.
• The transfer of Class B Shares from the reporting person and the GST-Exempt Legorreta 2020 Family Trust to PL RPH AIV, LLC, which is solely beneficially owned by the reporting person, is a related party transaction.

Stakeholder Impact

• The transactions do not appear to have a direct impact on stakeholders, as they are transfers and gifts rather than open market transactions.

Key Dates

Keywords

Form 4, beneficial ownership, Royalty Pharma, RPRX, Pablo Legorreta, Class B Shares, Class A Shares, share transfer, exempt gift